Buprenorphine Hcl Tablet
Product Images NDC 70518-2226

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Buprenorphine Hcl (NDC 70518-2226). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Buprenorphine 2mg 70518 2226 01

Buprenorphine  2mg 70518 2226 01
Label for Buprenorphine HCl 2 mg sublingual tablets, quantity of 30, Schedule III controlled substance. The label indicates prescription use only, repackaged by RemedyRepack Inc., with manufacturer listed as Hikma Pharmaceuticals USA Inc. Includes NDC 70518-2226-01 and cautions against transfer to others.*
FDA Label Image

Buprenorphine 2mg 70518 2226 02

Buprenorphine  2mg 70518 2226 02
Buprenorphine HCl 2 mg sublingual tablets packaging label showing quantity of 60 tablets. The label specifies Schedule C-III classification and RX only status. Manufactured by Hikma Pharmaceuticals USA Inc. and repackaged by RemedyRepack Inc. Includes NDC number 70518-2226-02 and storage instructions.*
FDA Label Image

Buprenorphine 2mg 70518 2226 03

Buprenorphine  2mg 70518 2226 03
Label for Buprenorphine HCl 2 mg sublingual tablets, packaged in a quantity of 90 tablets. The label shows the Controlled Substance Schedule C-III and indicates RX only use. The product is repackaged by RemedyRepack Inc. The label includes a QR code, NDC 70518-2226-03, and manufacturer info: Hikma Pharmaceuticals USA Inc., Eatontown, NJ.*
FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Packaging label for Buprenorphine HCl sublingual tablets, 2 mg strength. The label indicates a quantity of 30 tablets and classifies the drug as C-III with RX only status. The product is repackaged by RemedyRepack Inc. The label includes NDC number 70518-2226-00, manufacturer Hikma Pharmaceuticals USA Inc., and storage instructions.*
FDA Label Image

Bup HCl Chem Fig

Bup HCl Chem Fig
Chemical structure of Buprenorphine Hydrochloride (Buprenorphine HCl) as depicted in the image, showing a detailed molecular diagram with key functional groups and bonds visible.*
FDA Label Image

Ifu Image

Ifu Image
An instructional illustration showing a person placing a tablet under their tongue, demonstrating sublingual administration of a medication.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.